Members of the Sackler family who own Purdue Pharma have reached a deal with U.S. states to pay as much as $6 billion in cash to end widespread litigation against the OxyContin maker over its role in the nation's opioid epidemic.
Why it matters: The deal, which was announced on Thursday but still must be approved by a judge, would give states and local governments billions of dollars for treatment programs.
